已发表论文

睡眠时间对上海方舱医院 SARS-CoV-2 感染合并高血压急症患者血压的影响

 

Authors Shi JH, Ding J, Cheng H, Fang H, Zhu J 

Received 6 May 2023

Accepted for publication 15 June 2023

Published 21 June 2023 Volume 2023:16 Pages 3981—3988

DOI https://doi.org/10.2147/IDR.S420182

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Professor Suresh Antony

Objective: To evaluate the effect of sleep duration on blood pressure in patients with hypertension urgencies combined with SARS-CoV-2 infection in a Fangcang shelter hospital.
Methods: From April 10, 2020 to May 20, 2022, we statistically analyzed the blood pressure and sleep conditions of 52 patients with combined hypertension urgencies and SARS-CoV-2 infection admitted in Shanghai National Convention and Exhibition Center Fangcang shelter hospital. They were divided into the short-term (daily sleep duration: < 7 h) and normal sleep group (7– 9 h). We performed a comparison of the control effects of basic antihypertensive drugs. Additionally, patients in the short-term sleep group underwent drug therapy for sleep regulation and continuous monitoring of blood pressure.
Results: Among these patients, the blood pressure was higher in the short-term sleep group than that of the normal sleep group, and also more difficult to control (< 0.05). Furthermore, the blood pressure of the patients in the short-term sleep group was more easily controlled after treatment with drugs for sleep regulation and basic antihypertensive drugs (< 0.05).
Conclusion: The blood pressure level in patients with combined SARS-CoV-2 infection and hypertension urgencies was higher in those with a shorter duration of daily sleep, and also more difficult to control in Fangcang shelter hospital. Drug therapy for sleep regulation should be administered early to obtain sufficient blood pressure control effects.
Keywords: hypertension urgencies, shelter hospital, sleep regulation, Fangcang hospital, blood pressure, short-term sleep, SARS-CoV-2, COVID-19